Upstream and Downstream Processing

Featured on Upstream and Downstream Processing

Podcast: Lumen using spirulina to make ‘edible’ antibody drugs
BPI Podcasts
Podcast: Lumen using spirulina to make ‘edible’ antibody drugsPodcast: Lumen using spirulina to make ‘edible’ antibody drugs

byDan Stanton
Jul 25, 2022
Podcast: Cytiva cites COVID as driver for biopharma resilience
BPI Podcasts
Podcast: Cytiva cites COVID as driver for biopharma resiliencePodcast: Cytiva cites COVID as driver for biopharma resilience
byDan Stanton
Jul 15, 2022
MilliporeSigma to equip ex-BMS plant in strategic partnership with Lotte
Upstream & Downstream Processing
MilliporeSigma to equip ex-BMS plant in strategic partnership with LotteMilliporeSigma to equip ex-BMS plant in strategic partnership with Lotte
byDan Stanton
Jul 1, 2022
2 Min Read
Invetech launches closed autologous cell therapy tech
Upstream & Downstream Processing
Invetech launches closed autologous cell therapy techInvetech launches closed autologous cell therapy tech
byDan Stanton
Jun 22, 2022
1 Min Read
BPI Europe: three minutes, three Danaher tech platforms
Upstream & Downstream Processing
BPI Europe: three minutes, three Danaher tech platformsBPI Europe: three minutes, three Danaher tech platforms
byMillie Nelson
Jun 13, 2022
1 Min Read
MigVax taps Catalent to deliver COVID-19 vaccine orally
Upstream & Downstream Processing
MigVax taps Catalent to deliver COVID-19 vaccine orallyMigVax taps Catalent to deliver COVID-19 vaccine orally
byDan Stanton
Jun 9, 2022
2 Min Read

More from Upstream and Downstream Processing

High cost of complex biomanufacturing ‘a problem worth solving,’ says Waters
Upstream & Downstream Processing
High cost of complex biomanufacturing ‘a problem worth solving,’ says Waters
High cost of complex biomanufacturing ‘a problem worth solving,’ says Waters
May 25, 2022
|
3 Min Read
byDan Stanton
MilliporeSigma pumps $470m into Ireland filtration plants
Upstream & Downstream Processing
MilliporeSigma pumps $470m into Ireland filtration plants
MilliporeSigma pumps $470m into Ireland filtration plants
May 23, 2022
|
2 Min Read
byDan Stanton
Dover shells out $225m for bio-control instruments firm Malema
Deal-Making
Dover shells out $225m for bio-control instruments firm Malema
Dover shells out $225m for bio-control instruments firm Malema
May 11, 2022
|
1 Min Read
byDan Stanton
Cytiva opening Swiss single-use cell processing site
Upstream & Downstream Processing
Cytiva opening Swiss single-use cell processing site
Cytiva opening Swiss single-use cell processing site
May 10, 2022
|
2 Min Read
byDan Stanton
Repligen: Robust bioprocess market will offset reduced COVID demand
Upstream & Downstream Processing
Repligen: Robust bioprocess market will offset reduced COVID demand
Repligen: Robust bioprocess market will offset reduced COVID demand
May 3, 2022
|
2 Min Read
byDan Stanton
Formulation lap: Sanofi turns to McLaren for manufacturing efficiency
Upstream & Downstream Processing
Formulation lap: Sanofi turns to McLaren for manufacturing efficiency
Formulation lap: Sanofi turns to McLaren for manufacturing efficiency
Apr 27, 2022
|
2 Min Read
byDan Stanton
Danaher and Sartorius: COVID just one variable affecting bioprocess growth
Upstream & Downstream Processing
Danaher and Sartorius: COVID just one variable affecting bioprocess growth
Danaher and Sartorius: COVID just one variable affecting bioprocess growth
Apr 25, 2022
|
4 Min Read
byDan Stanton
MAST away: Lonza sells bioreactor sampling tech to MilliporeSigma
Upstream & Downstream Processing
MAST away: Lonza sells bioreactor sampling tech to MilliporeSigma
MAST away: Lonza sells bioreactor sampling tech to MilliporeSigma
Apr 11, 2022
|
2 Min Read
byDan Stanton
Evonetix hits milestone in development of DNA synthesis
Upstream & Downstream Processing
Evonetix hits milestone in development of DNA synthesis
Evonetix hits milestone in development of DNA synthesis
Mar 9, 2022
|
3 Min Read
byMillie Nelson
The 4 degrees of automation in cell therapy manufacture
Therapeutic Class
The 4 degrees of automation in cell therapy manufacture
The 4 degrees of automation in cell therapy manufacture
Mar 8, 2022
|
3 Min Read
byDan Stanton
Maravai LifeSciences: $11bn+ would deliver Sartorius a nucleic acid unit
Upstream & Downstream Processing
Maravai LifeSciences: $11bn+ would deliver Sartorius a nucleic acid unit
Maravai LifeSciences: $11bn+ would deliver Sartorius a nucleic acid unit
Mar 1, 2022
|
2 Min Read
byDan Stanton
eBook: Gene Therapies &mdash;<br> Developers Slowly Emerge from a Pandemic
Cell Therapies
eBook: Gene Therapies — Developers Slowly Emerge from a Pandemic
eBook: Gene Therapies — Developers Slowly Emerge from a Pandemic
Feb 18, 2022
byDan Stanton, Gareth Macdonald
Twist leaves gene production problems behind; looks to ‘Factory of the Future’
Upstream & Downstream Processing
Twist leaves gene production problems behind; looks to ‘Factory of the Future’
Twist leaves gene production problems behind; looks to ‘Factory of the Future’
Feb 9, 2022
|
2 Min Read
byDan Stanton
Thermo’s $39bn+ sales driven by 25% y-o-y biopharma growth
Upstream & Downstream Processing
Thermo’s $39bn+ sales driven by 25% y-o-y biopharma growth
Thermo’s $39bn+ sales driven by 25% y-o-y biopharma growth
Feb 7, 2022
|
2 Min Read
byGareth Macdonald
CDMO Arranta buys Cytiva single-use tech for mRNA production
Upstream & Downstream Processing
CDMO Arranta buys Cytiva single-use tech for mRNA production
CDMO Arranta buys Cytiva single-use tech for mRNA production
Jan 27, 2022
|
2 Min Read
byGareth Macdonald
HPNE to expand single-use capacity on back of $15m BARDA contract
Upstream & Downstream Processing
HPNE to expand single-use capacity on back of $15m BARDA contract
HPNE to expand single-use capacity on back of $15m BARDA contract
Jan 20, 2022
|
2 Min Read
byDan Stanton
Danaher: $10bn+ war chest in 2022 but sees no gaps in bioprocessing
Upstream & Downstream Processing
Danaher: $10bn+ war chest in 2022 but sees no gaps in bioprocessing
Danaher: $10bn+ war chest in 2022 but sees no gaps in bioprocessing
Jan 13, 2022
|
2 Min Read
byDan Stanton
Thermo Fisher buys recombinant protein maker PeproTech for $1.85bn
Deal-Making
Thermo Fisher buys recombinant protein maker PeproTech for $1.85bn
Thermo Fisher buys recombinant protein maker PeproTech for $1.85bn
Jan 6, 2022
|
2 Min Read
byDan Stanton
Bioanalytics booster: Sartorius takes stake in Automated Lab Solutions
Upstream & Downstream Processing
Bioanalytics booster: Sartorius takes stake in Automated Lab Solutions
Bioanalytics booster: Sartorius takes stake in Automated Lab Solutions
Jan 4, 2022
|
2 Min Read
byDan Stanton
Digital transformation must be driven by technology and savvy staff
Upstream & Downstream Processing
Digital transformation must be driven by technology and savvy staff
Digital transformation must be driven by technology and savvy staff
Dec 20, 2021
|
2 Min Read
byGareth Macdonald
Danaher and COVID: $2bn orders for 2022 without potential Omicron windfall
Upstream & Downstream Processing
Danaher and COVID: $2bn orders for 2022 without potential Omicron windfall
Danaher and COVID: $2bn orders for 2022 without potential Omicron windfall
Dec 6, 2021
|
2 Min Read
byDan Stanton
Scaling-up AAV production? Take your time to develop best processes
Upstream & Downstream Processing
Scaling-up AAV production? Take your time to develop best processes
Scaling-up AAV production? Take your time to develop best processes
Nov 23, 2021
|
3 Min Read
byDan Stanton
Generate Biomedicines raises $370m to advance AI drug discovery tech
Upstream & Downstream Processing
Generate Biomedicines raises $370m to advance AI drug discovery tech
Generate Biomedicines raises $370m to advance AI drug discovery tech
Nov 22, 2021
|
1 Min Read
byGareth Macdonald
Thermo Fisher and 3M team on chromatography tech
Upstream & Downstream Processing
Thermo Fisher and 3M team on chromatography tech
Thermo Fisher and 3M team on chromatography tech
Nov 15, 2021
|
2 Min Read
byDan Stanton
Ins and outs: Avid create viral vector position to lead CGT expansion
Deal-Making
Ins and outs: Avid create viral vector position to lead CGT expansion
Ins and outs: Avid create viral vector position to lead CGT expansion
Nov 8, 2021
|
2 Min Read
byMillie Nelson
Lose the LIMS? Bristol Myers says QC labs of the future need to be digital
Upstream & Downstream Processing
Lose the LIMS? Bristol Myers says QC labs of the future need to be digital
Lose the LIMS? Bristol Myers says QC labs of the future need to be digital
Nov 1, 2021
|
3 Min Read
byGareth Macdonald
Aceto buffers up presence in bioprocessing with A&C buy
Upstream & Downstream Processing
Aceto buffers up presence in bioprocessing with A&C buy
Aceto buffers up presence in bioprocessing with A&C buy
Oct 13, 2021
|
2 Min Read
byDan Stanton
Simulated Bed fellows: Tosoh buys purification firm Semba
Upstream & Downstream Processing
Simulated Bed fellows: Tosoh buys purification firm Semba
Simulated Bed fellows: Tosoh buys purification firm Semba
Oct 11, 2021
|
3 Min Read
byDan Stanton
MilliporeSigma says viscosity tech overcomes manufacturing challenges
Upstream & Downstream Processing
MilliporeSigma says viscosity tech overcomes manufacturing challenges
MilliporeSigma says viscosity tech overcomes manufacturing challenges
Oct 6, 2021
|
2 Min Read
byMillie Nelson
Gamma invests in bio-sensor and analytics firm Nirrin
Upstream & Downstream Processing
Gamma invests in bio-sensor and analytics firm Nirrin
Gamma invests in bio-sensor and analytics firm Nirrin
Sep 28, 2021
|
2 Min Read
byDan Stanton

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: From Concept to Cleanroom - Case Studies in Single-Use Fluid Management CollaborationRegister Now: From Concept to Cleanroom - Case Studies in Single-Use Fluid Management Collaboration
Ask the Expert webcasts
ATE Webcasts
Register Now: Process Intensification Through Perfused N-1 BioreactorRegister Now: Process Intensification Through Perfused N-1 Bioreactor
Ask the Expert webcasts
ATE Webcasts
Register Now: Building Reliability Into Scale-Up: Targeted Optimization for AAV ProductionRegister Now: Building Reliability Into Scale-Up: Targeted Optimization for AAV Production
Insider News
See all
Sep 23 - Sep 26, 2024
Learn from the brightest minds in bioprocessing! The BPI US 2024 scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production.
Learn More

Innovative Technology

Thermo Fisher Plan for Success WP
Sponsored Content
Increase Efficiency and Reduce Costs in Bioprocessing: A Strategic GuideIncrease Efficiency and Reduce Costs in Bioprocessing: A Strategic Guide
byBPI Contributor
Aug 14, 2024
1 Min Read
Valgenesis transforming pharmaceutical development
Sponsored Content
Transforming Pharmaceutical Development: Combining Digital Platforms and QbD PrinciplesTransforming Pharmaceutical Development: Combining Digital Platforms and QbD Principles
byBPI Contributor
Aug 7, 2024
1 Min Read
Thermo Maximizing Scale Up
Sponsored Content
Navigating the Complexities of Buffer Preparation in Biopharmaceutical ManufacturingNavigating the Complexities of Buffer Preparation in Biopharmaceutical Manufacturing
byBPI Contributor
Aug 5, 2024
1 Min Read